LGND Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:49):
Our systems believe the stock currently is undervalued by 0.02% compare to its pairs and should correct upwards.

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide...

Stats
Dagens volum	49 064
Gjennomsnittsvolum	143 814
Markedsverdi	1.41B
EPS	$4.86 ( Q1 \| 2024-05-08 )
Neste inntjeningsdato	( $0 ) 2024-08-06
Last Dividend	$0.456 ( 2010-07-02 )
Next Dividend	$0 ( N/A )
P/E	14.63 (Sector) 42.63 (Industry) 24.32
ATR14	$0.111 (0.14%)

AADI -5.88%

ABCL 1.10%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 1.40%

ABSI 3.74%

ABUS -1.31%

ABVX -3.00%

ACAD -0.51%

ACER -17.95%

ACET -9.39%

ACGN 1.29%

ACHL -1.70%

ACHV 2.59%

ACIU -0.62%

ACLX -0.63%

ACRV -3.80%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.87%

ADGI 0.87%

ADIL -2.63%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.01%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -3.77%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.21%

AKRO -2.21%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS -0.37%

ALKS 1.86%

ALLK -11.44%

ALLO -2.29%

ALLR -2.64%

ALNA 3.16%

ALNY 2.20%

ALPN 0.02%

ALPX 0.00%

ALRN -2.17%

ALT -15.00%

ALVR -0.63%

ALXN 0.00%

ALXO -10.50%

ALZN 5.10%

AMRN -4.55%

AMTI -3.13%

ANAB 1.47%

ANEB 7.95%

ANGN 0.00%

ANIX -3.25%

ANL -0.14%

ANNX 3.17%

ANPC -3.15%

APGE 2.08%

APGN 8.48%

APGNW 30.65%

APLM -3.25%

APLS 0.15%

APLT 1.35%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.21%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 2.41%

ARGX -0.96%

ARNA 0.00%

ARPO -0.90%

ARQT -3.65%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.07%

ARWR -2.23%

ASLN -2.45%

ASMB -7.03%

ASND -2.30%

ATAI -3.33%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.85%

ATRA -6.30%

ATXI 1.09%

ATXS -0.34%

AUPH -0.81%

AURA 4.85%

AUTL -3.30%

AVBP -1.83%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.68%

AVTX -4.26%

AVXL -5.67%

AXLA 0.00%

AXSM -1.33%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.28%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.89%

BCTX 13.32%

BCTXW 1.97%

BCYC 0.80%

BDRX -5.55%

BDTX 0.32%

BEAM 2.72%

BFRA -2.91%

BGNE -2.68%

BIOR -3.83%

BIVI 1.72%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.07%

BLU 0.03%

BLUE -4.46%

BMEA -14.78%

BMRN 0.07%

BNOX 4.46%

BNTC -2.95%

BNTX -2.23%

BOLD -11.06%

BOLT 0.32%

BPMC -2.39%

BPTH -4.74%

BPTS -13.47%

BRNS -0.37%

BRTX -6.21%

BTAI 12.61%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 0.83%

CADL 1.42%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.43%

CARA -11.68%

CARM 6.18%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.03%

CCCC -1.59%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.48%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.19%

CDXC 9.85%

CDXS 9.66%

CELC -3.18%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.45%

CERO -5.02%

CEROW -10.18%

CFRX -27.95%

CGEM 0.27%

CGEN -3.59%

CGON -2.89%

CGTX -3.41%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING -3.91%

CINGW 34.95%

CKPT -1.68%

CLBS -16.75%

CLDX -0.66%

CLGN -0.50%

CLLS -3.11%

CLNN -2.50%

CLNNW 0.00%

CLRB 6.67%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 2.24%

CMPI 0.00%

CMPX 0.94%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.43%

CNCE 0.00%

CNSP -33.74%

CNST 0.00%

CNTA 0.84%

CNTB -1.50%

CNTX -7.76%

COCP -1.83%

COEPW 32.45%

COGT -2.76%

CORT 3.42%

COYA -2.44%

CPRX -1.42%

CRBP -1.53%

CRBU -7.95%

CRDF 2.43%

CRGX -1.21%

CRIS -2.64%

CRNX -5.95%

CRSP 0.85%

CRTX 2.63%

CRVO -7.45%

CRVS 0.28%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -1.65%

CTNM 5.57%

CTXR -4.87%

CUE -3.11%

CVAC -4.94%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 19.63%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -3.00%

CYTO 0.00%

DARE 0.86%

DAWN -0.11%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.97%

DNLI -1.88%

DNTH -2.03%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.14%

ELEV -1.87%

ELOX 10.77%

ELTX -3.38%

ELVN -1.21%

ELYM 5.86%

ENGN 0.49%

ENGNW -21.67%

ENLV 0.74%

ENOB 1.79%

ENSC 6.55%

ENTA -0.90%

ENTO -4.97%

ENTX -1.60%

ENVB -0.02%

EPIX -0.82%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.84%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.11%

ETON 2.44%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.23%

EXAI -0.38%

EXEL 0.88%

EYEG -0.69%

EYEN 0.00%

EYPT -0.06%

FATE -12.23%

FBIO 0.89%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.04%

FDMT -4.68%

FENC -2.65%

FGEN -9.87%

FHTX 9.16%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.93%

FULC 2.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -0.77%

GBIO -0.71%

GBT 0.01%

GDTC 2.05%

GERN -1.44%

GHRS -4.27%

GLMD -2.48%

GLPG -1.83%

GLSI 10.66%

GLTO -3.90%

GLUE -2.37%

GLYC -15.04%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -7.00%

GOVX -6.73%

GOVXW 10.89%

GPCR -5.51%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.20%

GRTX -1.66%

GTHX 2.27%

GUTS 0.69%

GXGXW 41.67%

GYRE -5.95%

HALO -0.80%

HARP 0.09%

HCWB -3.76%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.54%

HOOK 1.17%

HOTH -3.78%

HOWL 0.21%

HRMY 3.35%

HRTX 8.85%

HSTO 0.00%

HUMA 1.62%

HUMAW -6.25%

IBRX -5.91%

ICCC -2.10%

ICPT 0.21%

ICU 19.03%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.10%

IFRX -3.14%

IGMS -1.54%

IKNA -1.79%

IKT -2.08%

IMAB -0.58%

IMCR -3.47%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -3.04%

IMNM 3.73%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.33%

IMTXW 6.00%

IMUX -6.42%

IMV 0.00%

IMVT -3.99%

INAB -1.12%

INBX -3.27%

INCY -2.08%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 1.82%

INO 1.82%

INSM -0.95%

INTS -3.73%

INVA 0.96%

INZY 1.14%

IOBT -7.09%

IONS 1.53%

IOVA -3.91%

IPA 1.08%

IPHA 2.54%

IPSC -2.34%

IRON -1.75%

ISEE 0.38%

ITOS 2.80%

ITRM 1.36%

IVA 6.96%

IVVD 0.41%

JAGX 0.26%

JANX -4.75%

JAZZ -0.73%

JNCE 0.00%

JSPR -1.83%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.60%

KDNY 0.22%

KMPH -0.34%

KNSA -2.58%

KNTE -0.38%

KOD -8.89%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 0.99%

KTRA 9.62%

KTTA -0.65%

KTTAW 0.92%

KURA 0.98%

KYMR -3.44%

KYTX -5.56%

KZIA 6.13%

KZR -1.48%

LABP 0.57%

LBPH 0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.80%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -4.36%

LPTX -1.10%

LQDA 0.24%

LRMR -0.64%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -5.15%

LXEO -13.02%

LXRX -0.88%

LYEL -36.03%

LYRA 4.18%

MACK 0.10%

MBIO -11.98%

MBRX -1.43%

MCRB 0.59%

MDGL -1.71%

MDNA -13.16%

MDWD 3.34%

MDXG -1.47%

MEIP 0.70%

MESO -1.41%

MGNX -5.36%

MGTA -7.74%

MGTX 0.95%

MGX -0.54%

MIRM -0.39%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 1.05%

MLYS -8.46%

MNKD -0.67%

MNMD 2.90%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -2.91%

MREO 0.14%

MRKR -0.43%

MRNA -10.74%

MRNS -6.62%

MRSN -3.58%

MRTX -0.17%

MRUS 0.81%

MRVI 1.60%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.64%

MYMD 2.16%

NAMS -0.13%

NAMSW 0.64%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.60%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.77%

NLSP 5.63%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 12.72%

NRIX -1.54%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.63%

NTRBW -31.07%

NUVL -1.95%

NVAX -5.86%

NVCT -8.45%

NVIV -34.28%

NXTC -6.71%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO 0.29%

OBSV 0.00%

OCEA -3.52%

OCGN 6.78%

OCS -1.00%

OCUL 0.69%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.43%

OMER -2.44%

OMGA -2.50%

ONCO 6.17%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.87%

ONTX -0.47%

ONVO 1.01%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.26%

ORMP 16.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.14%

OVID 0.40%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 5.07%

PCSA 0.00%

PCVX 0.72%

PDSB -4.75%

PEPG 1.52%

PGEN -6.59%

PHAR 1.99%

PHAS 0.00%

PHAT 0.10%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.56%

PLUR 10.34%

PMN -5.55%

PMVP -0.89%

PNT 0.16%

PPBT 1.64%

PRAX 4.70%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.79%

PRQR 1.20%

PRTA -3.64%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -5.04%

PTCT 0.19%

PTE -0.82%

PTGX 0.63%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -28.60%

QSIAW -9.44%

QTTB 4.58%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.79%

RARE 2.12%

RCKT -10.21%

REGN -0.20%

RENB -3.42%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.35%

RGLS -5.62%

RGNX -6.25%

RIGL -6.25%

RLAY -5.71%

RLMD -0.33%

RLYB -5.70%

RNA 2.67%

RNAC 3.37%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -2.48%

RPRX -0.80%

RPTX -1.03%

RUBY 2.70%

RVLP -32.05%

RVMD -0.54%

RVMDW -29.90%

RVNC -0.43%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.97%

RYTM -5.56%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.83%

SANA -2.12%

SAVA -4.07%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.16%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.04%

SGMT -4.35%

SGTX -2.56%

SIOX 22.63%

SLDB -2.24%

SLGL 5.23%

SLN -8.73%

SLNO 1.64%

SLRX 0.40%

SLS -3.85%

SMMT -3.31%

SNDX 2.20%

SNGX 4.45%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.63%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.66%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -6.88%

STRO -0.83%

STSA 0.00%

STTK 6.89%

SURF -0.93%

SVRA -1.84%

SWTX -0.14%

SYBX 0.00%

SYRS -1.73%

TALS -0.73%

TARA -7.14%

TARS -2.32%

TBPH 0.30%

TCBP 5.49%

TCDA 0.00%

TCON -1.34%

TCRR 0.00%

TCRT 4.49%

TCRX -2.58%

TECH -1.31%

TENX -0.32%

TERN -6.69%

TFFP -11.17%

TGTX -7.68%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -4.10%

TNXP -10.24%

TNYA -6.13%

TPST 4.59%

TRDA -4.77%

TRVI 1.92%

TRVN 3.15%

TSHA -16.76%

TSVT -4.39%

TTNP -6.05%

TVTX 3.83%

TYRA -7.23%

UBX -2.73%

UNCY -4.00%

URGN 3.76%

UTHR -0.41%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.65%

VCNX 5.44%

VCYT -0.97%

VERA -4.34%

VERU 1.40%

VERV -3.54%

VIGL 0.81%

VINC 2.81%

VIR -0.87%

VIRI -5.66%

VIRX 3.47%

VKTX -0.73%

VLON -13.04%

VNDA -3.01%

VOR -6.03%

VRCA 0.43%

VRDN -2.90%

VRNA -1.93%

VRPX 3.58%

VRTX -0.06%

VSTM 4.93%

VTGN -2.26%

VTVT 1.28%

VTYX -2.30%

VXRT -1.19%

VYGR -0.51%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.17%

XBIO 1.03%

XBIT 5.42%

XCUR 0.23%

XENE -0.91%

XERS 4.99%

XFOR 6.25%

XLO 3.06%

XLRN 0.00%

XNCR 0.31%

XOMA -6.99%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.76%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-14	Sabba Stephen L	Buy	1 252	Common Stock
2024-06-14	Sabba Stephen L	Buy	5 444	Non-Qualified Stock Option (right to buy)
2024-06-14	Zimmermann Martine	Buy	5 444	Non-Qualified Stock Option (right to buy)
2024-06-14	Zimmermann Martine	Buy	1 252	Common Stock
2024-06-14	Lamattina John L	Buy	1 252	Common Stock

INSIDER POWER
56.10
Last 99 transactions
Buy: 467 765 \| Sell: 133 743

Korrelasjon (AI algo v.1.1b): Undervalued: 0.02% $78.27 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.33 (neutral)

Kort: 0.42 (neutral)

Signal:(55.254) Neutral

Ligand Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ligand Pharmaceuticals Korrelasjon - Valuta/Råvare

0.10
( neutral )

-0.37
( neutral )

0.00
( neutral )

0.01
( neutral )

-0.41
( neutral )

0.35
( neutral )

Ligand Pharmaceuticals Økonomi

Annual	2023
Omsetning:	$131.31M
Bruttogevinst:	$119.75M (91.20 %)
EPS:	$3.02

FY	2023
Omsetning:	$131.31M
Bruttogevinst:	$119.75M (91.20 %)
EPS:	$3.02

FY	2022
Omsetning:	$196.25M
Bruttogevinst:	$143.42M (73.08 %)
EPS:	$-0.310

FY	2021
Omsetning:	$277.13M
Bruttogevinst:	$214.96M (77.56 %)
EPS:	$2.22

Financial Reports:

No articles found.

Ligand Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Ligand Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.60 - good (96.02%) | Divividend Growth Potential Score: 3.88 - No dividend growth expected in the near future

Information

First Dividend	$9.36	2007-04-03
Last Dividend	$0.456	2010-07-02
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$9.81	--
Avg. Dividend % Per Year	0.00%	--
Score	2.24	--
Div. Sustainability Score	9.60
Div.Growth Potential Score	3.88
Div. Directional Score	6.74	--

Next Divdend (Est)
(2026-09-30)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.24

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2007	$9.36	14.30%
2008	$0	0.00%
2009	$0	0.00%
2010	$0.456	3.50%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
02 Jul 2010	$0.456	30 Nov -0001	28 Jun 2010	30 Nov -0001
03 Apr 2007	$9.36	22 Mar 2007	05 Apr 2007	19 Apr 2007

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.793	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.103	1.200	6.58	7.89	[0 - 0.3]
returnOnEquityTTM	0.132	1.500	9.64	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	20.70	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	19.03	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.81	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00678	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	-1.073	1.000	-1.508	-1.508	[3 - 30]
operatingCashFlowPerShareTTM	1.935	2.00	9.35	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.971	2.00	-0.486	-0.971	[0 - 20]
debtEquityRatioTTM	0.00768	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.849	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0209	1.000	-2.42	-2.42	[0.1 - 0.6]
cashFlowToDebtRatioTTM	5.54	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.129	0.800	-2.47	-1.976	[0.5 - 2]
Total Score				9.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.91	1.000	8.59	0	[1 - 100]
returnOnEquityTTM	0.132	2.50	9.77	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.971	2.00	-0.324	-0.971	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.935	2.00	9.35	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.442	1.500	3.72	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.290	1.000	5.25	0	[0.1 - 0.5]
Total Score				3.88

Ligand Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California.